4DMedical Limited (ASX:4DX) Insider Acquires A$30,975.71 in Stock

4DMedical Limited (ASX:4DX) insider Julian Sutton bought 60,147 shares of the stock in a transaction on Wednesday, January 15th. The stock was purchased at an average cost of A$0.52 ($0.32) per share, with a total value of A$30,975.71 ($19,359.82).

4DMedical Stock Performance

The company has a quick ratio of 6.01, a current ratio of 1.78 and a debt-to-equity ratio of 7.22.

4DMedical Company Profile

4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lungs ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator.